Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its second quarter 2019 financial results on Thursday, August 1, 2019.
July 25, 2019
· 2 min read